Funded Tech Companies

Otonomy

Otonomy, operating out of San Diego, received equity investments through OrbiMed, TPG Biotech and Novo Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Otonomy (NASDAQ: OTIC) is a biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/13/2014

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Weber

        

Chief Financial Officer

Paul Cayer

        

Chief Technical Officer

Robert Savel

        

VP - Finance

Julie Burgess

        

VP - Human Resources

Carla da Luz Boren

        

Company Investors

• OrbiMed (Chau Khuong)
• TPG Biotech (Heather Preston)
• Novo Ventures (Peter Bisgaard)
• Domain Associates (Brian Dovey)
• Osage Partners
• Aperture Venture Partners
• Avalon Ventures (Jay Lichte)
• RiverVest Venture Partners (John McKearn)
• Federated Kaufmann Funds
• Avalon Ventures (Jay Lichter)

Browse more funded tech companies:

Otonomo | Otovo

Share this article

About Our VC Deals Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary